Consumption of Antibiotics in Primary Care Setting before and during COVID-19 Pandemic in Republic of Srpska, Bosnia and Herzegovina
Open Access
- 28 September 2022
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 11 (10) , 1319
Abstract
The pandemic of COVID-19 has brought many changes in health care systems at all levels of health care. The increase in the number of cases of COVID-19 has led to overuse and misuse of antibiotics.The aim of this study was to compare the consumption of antibiotics for systemic use in outpatients in the Republic of Srpska (RS), before and during the first year of the COVID-19 pandemic, as well as the association between antibiotic consumption and the rate of incidence and mortality of COVID-19. The total consumption of the antibiotics for systemic use (J01) in outpatients in the Republic of Srpska during 2019 was 19.40 DDD/TID, with an increase to 30.80 DDD/TID in 2020.Significantly higher use of penicillin (10.58 ± 11.01 DDD/TID in 2019 vs. 17.10 ± 13.63 DDD/TID in 2020), cephalosporins (2.68 ± 1.90 DDD/TID in 2019 vs. 5.93 ± 2.77 DDD/TID in 2020) and macrolides (2.14 ± 2.22 DDD/TID in 2019 vs. 3.40 ± 3.44 DDD/TID in 2020) was observed during the pandemic period. It is necessary to improve the prescribing practice of antibiotics at the primary health care level, public awareness about rational use of antibiotics, as well as the current antibiotic stewardship programs and control their implementation.Keywords
This publication has 21 references indexed in Scilit:
- Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacyJournal of Infection and Public Health, 2021
- Evolution of Antimicrobial Consumption During the First Wave of COVID-19 PandemicAntibiotics, 2021
- Changes in demand for emergency ambulances during a nationwide lockdown that resulted in elimination of COVID-19: an observational study from New ZealandBMJ Open, 2020
- Drug treatments for covid-19: living systematic review and network meta-analysisBMJ, 2020
- Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing GuidelinesDrug Safety, 2020
- COVID-19: don't neglect antimicrobial stewardship principles!Clinical Microbiology and Infection, 2020
- RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional surveyInternational Journal of Biological Sciences, 2020
- Global access to antibiotics without prescription in community pharmacies: A systematic review and meta-analysisJournal of Infection, 2019
- Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and ImplicationsFrontiers in Pharmacology, 2018